cardiotomskСибирский журнал клинической и экспериментальной медициныSiberian Journal of Clinical and Experimental Medicine2713-29272713-265XTSU publishing10.29001/2073-8552-2022-37-4-31-37cardiotomsk-1617Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESОсложнения со стороны сердечно-сосудистой системы при респираторных вирусных инфекцияхCardiovascular complications of respiratory viral infectionshttps://orcid.org/0000-0002-0962-5790ИшмурзинГ. П.IshmurzinG. P.

Ишмурзин Геннадий Петрович, кандидат медицинских наук, доцент кафедры внутренних болезней

420012, Казань, ул. Бутлерова, 49

Gennady P. Ishmurzin, Cand. Sci. (Med.), Associate Professor, Department of Internal Medicine

49, Butlerov str., Kazan, 420012, Tatarstan, Russian Federation

ishm08@mail.ruhttps://orcid.org/0000-0002-2608-7904СеребряковаО. А.SerebryakovaO. A.

Серебрякова Ольга Александровна, студент педиатрического факультета

420012, Казань, ул. Бутлерова, 49

Olga A. Serebryakova, Medical Student, Faculty of Pediatrics

49, Butlerov str., Kazan, 420012, Tatarstan, Russian Federation

serebrryakova@gmail.comhttps://orcid.org/0000-0003-3061-3150СюзевК. Н.SyuzevK. N.

Сюзев Кирилл Николаевич, младший научный сотрудник, кафедра общей патологии

420012, Казань, ул. Бутлерова, 49

Kirill  N.  Syuzev,  Junior  Research  Scientist,  Department  of  General Pathology

49, Butlerov str., Kazan, 420012, Tatarstan, Russian Federation

grop2019@gmail.comhttps://orcid.org/0000-0001-5444-6145ДолгановаД. А.DolganovaD. A.

Долганова Дарья Александровна, студент педиатрического факультета

420012, Казань, ул. Бутлерова, 49

Darya A. Dolganova, Medical Student, Faculty of Pediatrics

49, Butlerov str., Kazan, 420012, Tatarstan, Russian Federation

dasha_777_dasha@mail.ruhttps://orcid.org/0000-0001-5196-2566ГайнуллинаА. Х.GainullinaA. Kh.

Гайнуллина Айгуль Халилевна, студент педиатрического факультета

420012, Казань, ул. Бутлерова, 49

Aigul Kh. Gainullina, Medical Student, Faculty of Pediatrics

49, Butlerov str., Kazan, 420012, Tatarstan, Russian Federation

aygul.gaynullina.99@mail.ruКазанский государственный медицинский университет Министерства здравоохранения Российской ФедерацииРоссияKazan State Medical UniversityRussian Federation2022160120233743137Copyright © Ишмурзин Г.П., Серебрякова О.А., Сюзев К.Н., Долганова Д.А., Гайнуллина А.Х., 20232023Ишмурзин Г.П., Серебрякова О.А., Сюзев К.Н., Долганова Д.А., Гайнуллина А.Х.Ishmurzin G.P., Serebryakova O.A., Syuzev K.N., Dolganova D.A., Gainullina A.K.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sibjcem.ru/jour/article/view/1617

Несмотря на значительный прогресс в понимании патогенеза вирусных болезней и способов их лечения, один только вирус гриппа вызывает до 35 млн тяжелых случаев заболевания и 250–500 тыс. смертей ежегодно. Однако респираторные вирусы способны влиять не только на дыхательную систему, но и в том числе вызывать осложнения со стороны сердечно-сосудистой системы (ССС), такие как: острый коронарный синдром (ОКС), миокардиты и перикардиты, обострение хронической сердечной недостаточности (ХСН), острая сердечная недостаточность, тромбоэмболия легочной артерии и аритмии. В данном обзоре представлена информация о частоте встречаемости сердечно-сосудистых осложнений, возникших в ассоциации с перенесенными острыми респираторными вирусными инфекциями (новая коронавирусная инфекция, грипп, РС-инфекция, аденои риновирусные инфекции), механизмах влияния респираторных вирусов на ССС. Понимание данных механизмов позволит предвидеть возможные сердечнососудистые осложнения у пациентов с респираторными инфекциями, как можно раньше предпринять меры для быстрого их купирования, особенно при жизнеугрожающих состояниях.

Despite significant progress in understanding the pathogenesis and treatment of viral diseases, the influenza virus alone causes up to three to five million severe cases and 250-500 thousand deaths annually. However, respiratory viruses can affect not only the respiratory system, but also cause complications in the cardiovascular system. For example, acute coronary syndrome, myocarditis, pericarditis, exacerbation of chronic heart failure, acute heart failure, pulmonary embolism, and arrhythmias. This review provides information on the incidence of cardiovascular complications that occurred in association with acute respiratory viral infections (COVID-19, influenza, respiratory syncytial virus infection, adenovirus, and rhinovirus infections), and the mechanisms of respiratory virus impact on the cardiovascular system. Understanding these mechanisms may allow to predict the potential cardiovascular complications in patients with respiratory infections and take prompt measures to prevent them as soon as possible especially in case of life-threatening events.

факторы риска сердечно-сосудистых заболеванийCOVID-19гриппРС-вирусcardiovascular risk factorsCOVID-19influenzarespiratory syncytial virusReferencesFlora G.D., Nayak M.K. A Brief review of cardiovascular diseases, associated risk factors and current treatment regimes. Curr. Pharm. Des. 2019;25(38):4063–4084. DOI: 10.2174/1381612825666190925 163827.Flora G.D., Nayak M.K. A Brief review of cardiovascular diseases, associated risk factors and current treatment regimes. Curr. Pharm. Des. 2019;25(38):4063–4084. DOI: 10.2174/1381612825666190925 163827.Khayyam-Nekouei Z., Neshatdoost H., Yousefy A., Sadeghi M., Manshaee G. Psychological factors and coronary heart disease. ARYA Atheroscler. 2013;9(1):102–111.Khayyam-Nekouei Z., Neshatdoost H., Yousefy A., Sadeghi M., Manshaee G. Psychological factors and coronary heart disease. ARYA Atheroscler. 2013;9(1):102–111.Dhainaut J.-F., Claessens Y.-E., Janes J., Nelson D.R. Underlying disorders and their impact on the host response to infection. Clin. Infect. Dis. 2005;41(7):S481–S489. DOI: 10.1086/432001.Dhainaut J.-F., Claessens Y.-E., Janes J., Nelson D.R. Underlying disorders and their impact on the host response to infection. Clin. Infect. Dis. 2005;41(7):S481–S489. DOI: 10.1086/432001.Elezkurtaj S., Greuel S., Ihlow J., Michaelis E. G., Bischoff P., Kunze C.A. et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Sci. Rep. 2021;11(1):4263. DOI: 10.1038/s41598021-82862-5.Elezkurtaj S., Greuel S., Ihlow J., Michaelis E. G., Bischoff P., Kunze C.A. et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Sci. Rep. 2021;11(1):4263. DOI: 10.1038/s41598021-82862-5.Ketcham S.W., Bolig T.C., Molling D.J., Sjoding M.W., Flanders S.A., Prescott H.C. Causes and Circumstances of Death among Patients Hospitalized with COVID-19: A Retrospective Cohort Study. Ann. A. Thorac. Soc. 2021;18(6):1076–1079. DOI: 10.1513/AnnalsATS.202011-1381RL.Ketcham S.W., Bolig T.C., Molling D.J., Sjoding M.W., Flanders S.A., Prescott H.C. Causes and Circumstances of Death among Patients Hospitalized with COVID-19: A Retrospective Cohort Study. Ann. A. Thorac. Soc. 2021;18(6):1076–1079. DOI: 10.1513/AnnalsATS.202011-1381RL.Gopinathannair R., Merchant F.M., Lakkireddy D.R., Etheridge S.P., Feigofsky S., Han J.K. et al. COVID-19 and cardiac arrhythmias: A global perspective on arrhythmia characteristics and management strategies. J. Interv. Card. Electrophysiol. 2020;59(2):329–336. DOI: 10.1007/s10840-020-00789-9.Gopinathannair R., Merchant F.M., Lakkireddy D.R., Etheridge S.P., Feigofsky S., Han J.K. et al. COVID-19 and cardiac arrhythmias: A global perspective on arrhythmia characteristics and management strategies. J. Interv. Card. Electrophysiol. 2020;59(2):329–336. DOI: 10.1007/s10840-020-00789-9.Wichmann D., Sperhake J.P., Lütgehetmann M., Steurer S., Edler C., Heinemann A. et al. Autopsy Findings and Venous Thromboembolism in Patients with COVID-19: A Prospective Cohort Study. Ann. Intern. Med. 2020;173(4):268–277. DOI: 10.7326/M20-2003.Wichmann D., Sperhake J.P., Lütgehetmann M., Steurer S., Edler C., Heinemann A. et al. Autopsy Findings and Venous Thromboembolism in Patients with COVID-19: A Prospective Cohort Study. Ann. Intern. Med. 2020;173(4):268–277. DOI: 10.7326/M20-2003.Bellosta R., Luzzani L., Natalini G., Pegorer M.A., Attisani L., Cossu L.G. et al. Acute limb ischemia in patients with COVID-19 pneumonia. J. Vasc. Surg. 2020;72(6):1864–1872. DOI: 10.1016/j.jvs.2020.04.483.Bellosta R., Luzzani L., Natalini G., Pegorer M.A., Attisani L., Cossu L.G. et al. Acute limb ischemia in patients with COVID-19 pneumonia. J. Vasc. Surg. 2020;72(6):1864–1872. DOI: 10.1016/j.jvs.2020.04.483.Stefanini G.G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M. et al. ST-Elevation Myocardial infarction in patients with COVID-19: Clinical and angiographic outcomes. .Circulation. 2020;141(25):2113–2116. DOI: 10.1161/CIRCULATIONAHA.120.047525.Stefanini G.G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M. et al. ST-Elevation Myocardial infarction in patients with COVID-19: Clinical and angiographic outcomes. .Circulation. 2020;141(25):2113–2116. DOI: 10.1161/CIRCULATIONAHA.120.047525.Daniels C.J., Rajpal S., Greenshields J.T., Rosenthal G. L., Chung E.H., Terrin M. et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 Infection: Results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021;6(9):1078–1087. DOI: 10.1001/jamacardio.2021.2065.Daniels C.J., Rajpal S., Greenshields J.T., Rosenthal G. L., Chung E.H., Terrin M. et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 Infection: Results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021;6(9):1078–1087. DOI: 10.1001/jamacardio.2021.2065.Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265–1273. DOI: 10.1001/jamacardio.2020.3557.Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265–1273. DOI: 10.1001/jamacardio.2020.3557.Guo T., Fan Y., Chen M., Wu X., Zhang L., He T. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–818. DOI: 10.1001/jamacardio.2020.1017.Guo T., Fan Y., Chen M., Wu X., Zhang L., He T. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–818. DOI: 10.1001/jamacardio.2020.1017.Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395(10229):1054–1062. DOI: 10.1016/S0140-6736(20)30566-3.Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395(10229):1054–1062. DOI: 10.1016/S0140-6736(20)30566-3.Goyal P., Choi J.J., Pinheiro L.C., Schenck E. J., Chen R., Jabri A. et al. Clinical characteristics of COVID-19 in New York City. N. Engl. J. Med. 2020;382(24):2372–2374. DOI: 10.1056/NEJMc2010419.Goyal P., Choi J.J., Pinheiro L.C., Schenck E. J., Chen R., Jabri A. et al. Clinical characteristics of COVID-19 in New York City. N. Engl. J. Med. 2020;382(24):2372–2374. DOI: 10.1056/NEJMc2010419.Buckley B.J.R., Harrison S.L., Fazio-Eynullayeva E., Underhill P., Lane D.A., Lip G.Y.H. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur. J. Clin. Invest. 2021;51(11):e13679. DOI: 10.1111/eci.13679.Buckley B.J.R., Harrison S.L., Fazio-Eynullayeva E., Underhill P., Lane D.A., Lip G.Y.H. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur. J. Clin. Invest. 2021;51(11):e13679. DOI: 10.1111/eci.13679.Pillarisetti J., Cheema M.S., Haloot J., Panday M., Badin A., Mehta A. et al. Cardiac complications of COVID-19: Incidence and outcomes. Indian. Heart J. 2022;74(3):170–177. DOI: 10.1016/j.ihj.2022.04.008.Pillarisetti J., Cheema M.S., Haloot J., Panday M., Badin A., Mehta A. et al. Cardiac complications of COVID-19: Incidence and outcomes. Indian. Heart J. 2022;74(3):170–177. DOI: 10.1016/j.ihj.2022.04.008.Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. DOI: 10.1001/jama.2020.1585.Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. DOI: 10.1001/jama.2020.1585.Deng Q., Hu B., Zhang Y., Wang H., Zhou X., Hu W. et al. Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China. Int. J. Cardiol. 2020;311:116–121. DOI: 10.1016/j.ijcard.2020.03.087.Deng Q., Hu B., Zhang Y., Wang H., Zhou X., Hu W. et al. Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China. Int. J. Cardiol. 2020;311:116–121. DOI: 10.1016/j.ijcard.2020.03.087.Malas M.B., Naazie I.N., Elsayed N., Mathlouthi A., Marmor R., Clary B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine. 2020;29:100639. DOI: 10.1016/j.eclinm.2020.100639.Malas M.B., Naazie I.N., Elsayed N., Mathlouthi A., Marmor R., Clary B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine. 2020;29:100639. DOI: 10.1016/j.eclinm.2020.100639.Kollias A., Kyriakoulis K.G., Lagou S., Kontopantelis E., Stergiou G.S., Syrigos K. Venous thromboembolism in COVID-19: A systematic review and meta-analysis. Vasc. Med. 2021;26(4):415–425. DOI: 10.1177/1358863X21995566.Kollias A., Kyriakoulis K.G., Lagou S., Kontopantelis E., Stergiou G.S., Syrigos K. Venous thromboembolism in COVID-19: A systematic review and meta-analysis. Vasc. Med. 2021;26(4):415–425. DOI: 10.1177/1358863X21995566.Bristow M.R., Zisman L.S., Altman N.L., Gilbert E.M., Lowes B.D., Minobe A. et al. Dynamic regulation of SARS-Cov-2 binding and cell entry mechanisms in remodeled human ventricular myocardium. JACC Basic. Transl. Sci. 2020;5(9):871–883. DOI: 10.1016/j.jacbts.2020.06.007.Bristow M.R., Zisman L.S., Altman N.L., Gilbert E.M., Lowes B.D., Minobe A. et al. Dynamic regulation of SARS-Cov-2 binding and cell entry mechanisms in remodeled human ventricular myocardium. JACC Basic. Transl. Sci. 2020;5(9):871–883. DOI: 10.1016/j.jacbts.2020.06.007.Sharma A., Garcia G. Jr., Wang Y., Plummer J. T., Morizono K., Arumugaswami V. et al. Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 infection. Cell Rep. Med. 2020;1(4):100052. DOI: 10.1016/j.xcrm.2020.100052.Sharma A., Garcia G. Jr., Wang Y., Plummer J. T., Morizono K., Arumugaswami V. et al. Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 infection. Cell Rep. Med. 2020;1(4):100052. DOI: 10.1016/j.xcrm.2020.100052.Lindner D., Fitzek A., Bräuninger H., Aleshcheva G., Edler C., Meissner K. et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020;5(11):1281–1285. DOI:10.1001/jamacardio.2020.3551.Lindner D., Fitzek A., Bräuninger H., Aleshcheva G., Edler C., Meissner K. et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020;5(11):1281–1285. DOI:10.1001/jamacardio.2020.3551.Kogan E., Berezovskiy Y., Blagova O., Kukleva A., Semyonova L., Gretsov E. et al. Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19. Diagn. Pathol. 2022;17(1):31. DOI: 10.1186/s13000-02201207-6.Kogan E., Berezovskiy Y., Blagova O., Kukleva A., Semyonova L., Gretsov E. et al. Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19. Diagn. Pathol. 2022;17(1):31. DOI: 10.1186/s13000-02201207-6.Basso C., Leone O., Rizzo S., De Gaspari M., van der Wal A.C., Aubry M.C. et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur. Heart J. 2020;41(39):3827–3835. DOI: 10.1093/eurheartj/ehaa664.Basso C., Leone O., Rizzo S., De Gaspari M., van der Wal A.C., Aubry M.C. et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur. Heart J. 2020;41(39):3827–3835. DOI: 10.1093/eurheartj/ehaa664.Dolhnikoff M., Ferreira Ferranti J., de Almeida Monteiro R.A., DuarteNeto A.N., Soares Gomes-Gouvêa M., Viu Degaspare N. et al. SARSCoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome. Lancet Child Adolesc. Health. 2020;4(10):790– 794. DOI: 10.1016/S2352-4642(20)30257-1.Dolhnikoff M., Ferreira Ferranti J., de Almeida Monteiro R.A., DuarteNeto A.N., Soares Gomes-Gouvêa M., Viu Degaspare N. et al. SARSCoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome. Lancet Child Adolesc. Health. 2020;4(10):790– 794. DOI: 10.1016/S2352-4642(20)30257-1.Prabhu S.D. Cytokine-induced modulation of cardiac function. Circ. Res. 2004;95(12):1140–1153. DOI: 10.1161/01.RES.0000150734.79804.92.Prabhu S.D. Cytokine-induced modulation of cardiac function. Circ. Res. 2004;95(12):1140–1153. DOI: 10.1161/01.RES.0000150734.79804.92.McClenaghan C., Hanson A., Lee S.J., Nichols C.G. Coronavirus proteins as ion channels: Current and potential research. Front. Immunol. 2020;11:573339. DOI: 10.3389/fimmu.2020.573339.McClenaghan C., Hanson A., Lee S.J., Nichols C.G. Coronavirus proteins as ion channels: Current and potential research. Front. Immunol. 2020;11:573339. DOI: 10.3389/fimmu.2020.573339.Kwong J.C., Schwartz K.L., Campitelli M.A., Chung H., Crowcroft N.S., Karnauchow T. et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N. Engl. J. Med. 2018;378(4):345–353. DOI: 10.1056/NEJMoa1702090.Kwong J.C., Schwartz K.L., Campitelli M.A., Chung H., Crowcroft N.S., Karnauchow T. et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N. Engl. J. Med. 2018;378(4):345–353. DOI: 10.1056/NEJMoa1702090.Nguyen J.L., Yang W., Ito K., Matte T.D., Shaman J., Kinney P.L. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol. 2016;1(3):274–281. DOI: 10.1001/jamacardio.2016.0433.Nguyen J.L., Yang W., Ito K., Matte T.D., Shaman J., Kinney P.L. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol. 2016;1(3):274–281. DOI: 10.1001/jamacardio.2016.0433.Reichert T.A., Simonsen L., Sharma A., Pardo S.A., Fedson D.S., Miller M.A. Influenza and the winter increase in mortality in the United States, 1959–1999. Am. J. Epidemiol. 2004;160(5):492–502. DOI:10.1093/aje/ kwh227.Reichert T.A., Simonsen L., Sharma A., Pardo S.A., Fedson D.S., Miller M.A. Influenza and the winter increase in mortality in the United States, 1959–1999. Am. J. Epidemiol. 2004;160(5):492–502. DOI:10.1093/aje/ kwh227.Qi L., Li Q., Ding X.B., Gao Y., Ling H., Liu T. et al. Mortality burden from seasonal influenza in Chongqing, China, 2012–2018. Hum. Vaccin. Immunother. 2020;16(7):1668–1674. DOI: 10.1080/21645515.2019.1693721.Qi L., Li Q., Ding X.B., Gao Y., Ling H., Liu T. et al. Mortality burden from seasonal influenza in Chongqing, China, 2012–2018. Hum. Vaccin. Immunother. 2020;16(7):1668–1674. DOI: 10.1080/21645515.2019.1693721.Kumar K., Guirgis M., Zieroth S., Lo E., Menkis A.H., Arora R.C. et al. Influenza myocarditis and myositis: case presentation and review of the literature. Can. J. Cardiol. 2011;27(4):514–522. DOI: 10.1016/j. cjca.2011.03.005.Kumar K., Guirgis M., Zieroth S., Lo E., Menkis A.H., Arora R.C. et al. Influenza myocarditis and myositis: case presentation and review of the literature. Can. J. Cardiol. 2011;27(4):514–522. DOI: 10.1016/j. cjca.2011.03.005.Ukimura A., Satomi H., Ooi Y., Kanzaki Y. Myocarditis Associated with Influenza A H1N1pdm2009. Influenza Res. Treat. 2012;2012:351979. DOI: 10.1155/2012/351979.Ukimura A., Satomi H., Ooi Y., Kanzaki Y. Myocarditis Associated with Influenza A H1N1pdm2009. Influenza Res. Treat. 2012;2012:351979. DOI: 10.1155/2012/351979.Dolader P., Balcells J., Gran F. Influenza myocarditis in paediatric patients. Cardiol. Young. 2021;1–3. DOI: 10.1017/S1047951121004777.Dolader P., Balcells J., Gran F. Influenza myocarditis in paediatric patients. Cardiol. Young. 2021;1–3. DOI: 10.1017/S1047951121004777.Purdy A., Ido F., Sterner S., Tesoriero E., Matthews T., Singh A. Myocarditis in COVID-19 presenting with cardiogenic shock: А case series. Eur. Heart J. Case Rep. 2021;5(2):ytab028. DOI: 10.1093/ehjcr/ytab028.Purdy A., Ido F., Sterner S., Tesoriero E., Matthews T., Singh A. Myocarditis in COVID-19 presenting with cardiogenic shock: А case series. Eur. Heart J. Case Rep. 2021;5(2):ytab028. DOI: 10.1093/ehjcr/ytab028.Madjid M., Connolly A.T., Nabutovsky Y., Safavi-Naeini P., Razavi M., Miller C.C. Effect of high influenza activity on risk of ventricular arrhythmias requiring therapy in patients with implantable cardiac defibrillators and cardiac resynchronization therapy defibrillators. Am. J. Cardiol. 2019;124(1):44–50. DOI: 10.1016/j.amjcard.2019.04.011.Madjid M., Connolly A.T., Nabutovsky Y., Safavi-Naeini P., Razavi M., Miller C.C. Effect of high influenza activity on risk of ventricular arrhythmias requiring therapy in patients with implantable cardiac defibrillators and cardiac resynchronization therapy defibrillators. Am. J. Cardiol. 2019;124(1):44–50. DOI: 10.1016/j.amjcard.2019.04.011.Cheng W.L., Lin C.S. Transient atrioventricular block as a complication of influenza a virus: A case report. J. Acute Med. 2021;11(3):102–104. DOI: 10.6705/j.jacme.202109_11(3).0004.Cheng W.L., Lin C.S. Transient atrioventricular block as a complication of influenza a virus: A case report. J. Acute Med. 2021;11(3):102–104. DOI: 10.6705/j.jacme.202109_11(3).0004.Rivera-Guzmán N., Del Olmo-Arroyo F., Robles-Arías C.M., Rodríguez-Cintrón W. Transient AV block as a hemodynamic complication of the influenza a virus: A case report. P.R. Health Sci. J. 2016;35(3):173–175.Rivera-Guzmán N., Del Olmo-Arroyo F., Robles-Arías C.M., Rodríguez-Cintrón W. Transient AV block as a hemodynamic complication of the influenza a virus: A case report. P.R. Health Sci. J. 2016;35(3):173–175.Beinart R., Morganti K., Ruskin J., Mela T. H1N1 influenza A virus induced atrioventricular block. J. Cardiovasc. Electrophysiol. 2011;22(6):711– 713. DOI: 10.1111/j.1540-8167.2010.01931.x.Beinart R., Morganti K., Ruskin J., Mela T. H1N1 influenza A virus induced atrioventricular block. J. Cardiovasc. Electrophysiol. 2011;22(6):711– 713. DOI: 10.1111/j.1540-8167.2010.01931.x.Estabragh Z.R., Mamas M.A. The cardiovascular manifestations of influenza: a systematic review. Int. J. Cardiol. 2013;167(6):2397–2403. DOI: 10.1016/j.ijcard.2013.01.274.Estabragh Z.R., Mamas M.A. The cardiovascular manifestations of influenza: a systematic review. Int. J. Cardiol. 2013;167(6):2397–2403. DOI: 10.1016/j.ijcard.2013.01.274.Goshua G., Pine A.B., Meizlish M.L., Chang C.H., Zhang H., Bahel P. et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575–e582. DOI: 10.1016/S2352-3026(20)30216-7.Goshua G., Pine A.B., Meizlish M.L., Chang C.H., Zhang H., Bahel P. et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575–e582. DOI: 10.1016/S2352-3026(20)30216-7.Van Wissen M., Keller T.T., van Gorp E.C., Gerdes V.E., Meijers J.C., van Doornum G.J. et al. Acute respiratory tract infection leads to procoagulant changes in human subjects. J. Thromb. Haemost. 2011;9(7):1432– 1434. DOI: 10.1111/j.1538-7836.2011.04340.xVan Wissen M., Keller T.T., van Gorp E.C., Gerdes V.E., Meijers J.C., van Doornum G.J. et al. Acute respiratory tract infection leads to procoagulant changes in human subjects. J. Thromb. Haemost. 2011;9(7):1432– 1434. DOI: 10.1111/j.1538-7836.2011.04340.xSuo J., Zhao L., Wang J., Zhu Z., Zhang H., Gao R. Influenza virus aggravates the ox-LDL-induced apoptosis of human endothelial cells via promoting p53 signaling. J. Med. Virol. 2015;87(7):1113–1123. DOI: 10.1002/jmv.24166.Suo J., Zhao L., Wang J., Zhu Z., Zhang H., Gao R. Influenza virus aggravates the ox-LDL-induced apoptosis of human endothelial cells via promoting p53 signaling. J. Med. Virol. 2015;87(7):1113–1123. DOI: 10.1002/jmv.24166.Fang Y.A., Chen C.I., Liu J.C., Sung L.C. Influenza vaccination reduces hospitalization for heart failure in elderly patients with chronic kidney disease: A population-based cohort study. Acta Cardiol. Sin. 2016;32(3):290–298. DOI: 10.6515/acs20150424l.Fang Y.A., Chen C.I., Liu J.C., Sung L.C. Influenza vaccination reduces hospitalization for heart failure in elderly patients with chronic kidney disease: A population-based cohort study. Acta Cardiol. Sin. 2016;32(3):290–298. DOI: 10.6515/acs20150424l.Sung L.C., Chen C.I., Fang Y.A., Lai C.H., Hsu Y.P., Cheng T.H. et al. Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: A population-based cohort study. Vaccine. 2014;32(30):3843–3849. DOI: 10.1016/j.vaccine.2014.04.064.Sung L.C., Chen C.I., Fang Y.A., Lai C.H., Hsu Y.P., Cheng T.H. et al. Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: A population-based cohort study. Vaccine. 2014;32(30):3843–3849. DOI: 10.1016/j.vaccine.2014.04.064.Yedlapati S.H., Khan S.U., Talluri S., Lone A.N., Khan M.Z., Khan M.S. et al. Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: A systematic review and meta-analysis. J. Am. Heart Assoc. 2021;10(6):e019636. DOI: 10.1161/JAHA.120.019636.Yedlapati S.H., Khan S.U., Talluri S., Lone A.N., Khan M.Z., Khan M.S. et al. Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: A systematic review and meta-analysis. J. Am. Heart Assoc. 2021;10(6):e019636. DOI: 10.1161/JAHA.120.019636.Volling C., Hassan K., Mazzulli T., Green K., Al-Den A., Hunter P. et al. Respiratory syncytial virus infection-associated hospitalization in adults: А retrospective cohort study. BMC Infect. Dis. 2014;14:665. DOI: 10.1186/s12879-014-0665-2.Volling C., Hassan K., Mazzulli T., Green K., Al-Den A., Hunter P. et al. Respiratory syncytial virus infection-associated hospitalization in adults: А retrospective cohort study. BMC Infect. Dis. 2014;14:665. DOI: 10.1186/s12879-014-0665-2.Walsh E.E., Peterson D.R., Falsey A.R. Risk factors for severe respiratory syncytial virus infection in elderly persons. J. Infect. Dis. 2004;189(2):233–238. DOI: 10.1086/380907.Walsh E.E., Peterson D.R., Falsey A.R. Risk factors for severe respiratory syncytial virus infection in elderly persons. J. Infect. Dis. 2004;189(2):233–238. DOI: 10.1086/380907.Dowell S.F., Anderson L.J., Gary H.E. Jr., Erdman D.D., Plouffe J.F., File T.M. et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J. Infect. Dis. 1996;174(3):456–462. DOI: 10.1093/infdis/174.3.456.Dowell S.F., Anderson L.J., Gary H.E. Jr., Erdman D.D., Plouffe J.F., File T.M. et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J. Infect. Dis. 1996;174(3):456–462. DOI: 10.1093/infdis/174.3.456.Chuaychoo B., Ngamwongwan S., Kaewnaphan B., Athipanyasilp N., Horthongkham N., Kantakamalakul W. et al. Clinical manifestations and outcomes of respiratory syncytial virus infection in adult hospitalized patients. J. Clin. Virol. 2019;117:103–108. DOI: 10.1016/j.jcv.2019.07.001.Chuaychoo B., Ngamwongwan S., Kaewnaphan B., Athipanyasilp N., Horthongkham N., Kantakamalakul W. et al. Clinical manifestations and outcomes of respiratory syncytial virus infection in adult hospitalized patients. J. Clin. Virol. 2019;117:103–108. DOI: 10.1016/j.jcv.2019.07.001.Lee N., Lui G.C., Wong K.T., Li T.C., Tse E.C., Chan J.Y. et al. High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin. Infect. Dis. 2013;57(8):1069–1077. DOI: 10.1093/cid/ cit471.Lee N., Lui G.C., Wong K.T., Li T.C., Tse E.C., Chan J.Y. et al. High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin. Infect. Dis. 2013;57(8):1069–1077. DOI: 10.1093/cid/ cit471.Cebeci B., Oğuz D., Ataoğlu E., Elevli M., Yolcu C. Rhinovirus as a rare cause of acute onset dilated cardiomyopathy due to myocarditis in a newborn: case report and review of the literature. Turk. J. Pediatr. 2022;64(1):142–146. DOI: 10.24953/turkjped.2020.3664.Cebeci B., Oğuz D., Ataoğlu E., Elevli M., Yolcu C. Rhinovirus as a rare cause of acute onset dilated cardiomyopathy due to myocarditis in a newborn: case report and review of the literature. Turk. J. Pediatr. 2022;64(1):142–146. DOI: 10.24953/turkjped.2020.3664.Chow J., Murphy J., Subedi A., Jyothidasan A. Rhinovirus-associated dilated cardiomyopathy. IDCases. 2020;19:e00702. DOI: 10.1016/j. idcr.2020.e00702.Chow J., Murphy J., Subedi A., Jyothidasan A. Rhinovirus-associated dilated cardiomyopathy. IDCases. 2020;19:e00702. DOI: 10.1016/j. idcr.2020.e00702.Choi M.J., Song J.Y., Yang T.U., Jeon J.H., Noh J.Y., Hong K.W. et al. Acute myopericarditis caused by human Metapneumovirus. Infect. Chemother. 2016;48(1):36–40. DOI: 10.3947/ic.2016.48.1.36.Choi M.J., Song J.Y., Yang T.U., Jeon J.H., Noh J.Y., Hong K.W. et al. Acute myopericarditis caused by human Metapneumovirus. Infect. Chemother. 2016;48(1):36–40. DOI: 10.3947/ic.2016.48.1.36.Romero-Gómez M.P., Guereta L., Pareja-Grande J., Martínez-Alarcón J., Casas I., Ruiz-Carrascoso G. et al. Myocarditis caused by human parainfluenza virus in an immunocompetent child initially associated with 2009 influenza A (H1N1) virus. J. Clin. Microbiol. 2011;49(5):2072–2073. DOI: 10.1128/JCM.02638-10.Romero-Gómez M.P., Guereta L., Pareja-Grande J., Martínez-Alarcón J., Casas I., Ruiz-Carrascoso G. et al. Myocarditis caused by human parainfluenza virus in an immunocompetent child initially associated with 2009 influenza A (H1N1) virus. J. Clin. Microbiol. 2011;49(5):2072–2073. DOI: 10.1128/JCM.02638-10.

The authors declare that there are no conflicts of interest present.